TWM
TECH icon

TriaGen Wealth Management’s Bio-Techne TECH Stock Holding History

TriaGen Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,156
Closed -$382K – 201
2021
Q3 		$382K Buy
+3,156
New +$384K 0.21% 120

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TriaGen Wealth Management's TECH Position: Q4 2021 in Review

TriaGen Wealth Management sold out of Bio-Techne (TECH) in Q4 2021, closing a stake of 3,156 shares — an estimated $382K sold.

TriaGen Wealth Management first reported a position in TECH in Q3 2021 and held it in 1 quarter. The position peaked at $382K in Q3 2021. 575 funds tracked by Wall St. Rank hold TECH as of Q4 2021.

  • TriaGen Wealth Management reported no remaining Bio-Techne position as of Q4 2021 after selling out during the quarter.
  • TriaGen Wealth Management sold 3,156 Bio-Techne shares in Q4 2021, an estimated $382K.
  • TriaGen Wealth Management first reported a position in Bio-Techne in Q3 2021 and held it in 1 quarter.
  • TriaGen Wealth Management's Bio-Techne position peaked at $382K in Q3 2021.
  • 575 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2021.

Based on TriaGen Wealth Management's 13F filing for Q4 2021, filed 9 Feb 2022.